Alphasimplex Group, LLC Zoetis Inc. Transaction History

Alphasimplex Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$181.39 - $234.03 $105,568 - $136,205	-582 Reduced 27.48%	1,536 $290,000
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $436,502 - $483,545	-2,306 Reduced 52.12%	2,118 $411,000
Q1 2021 May 12, 2021	SELL	$144.0 - $169.39 $83,520 - $98,246	-580 Reduced 11.59%	4,424 $697,000
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $785,978 - $872,447	5,004 New	5,004 $828,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Alphasimplex Group, LLC with notifications on news.